Millipore - Pandemic Preparedness Program

As concerns over Influenza A (H1N1) rise we want to keep you informed on Millipore's preparedness. Millipore’s Global Operations group proactively monitors the latest news and threat levels and has implemented a Pandemic Preparedness Program. This web page will provide you with the latest information on Millipore’s efforts to ensure business continuity for our customers so that they can continue to make drugs and vaccines that will help maintain world health and safety.

Communications

A Letter to Millipore Customers from Robert Shaw, Program Director Vaccines and Emerging Biotech

Plans and Programs

Millipore’s Influenza A (H1N1) Virus Preparedness Program

Informational Websites

World Health Organization

Center for Disease Control

Other Resources

Influenza H1N1 Status: European Centre for Disease and Prevention Control

Influenza Information: National Institute of Allergy and Infectious Diseases (NIH)

FluWatch: Public Health Agency of Canada

Avian Influenza A (H5N1) Infection in Humans: Article from the New England Journal of Medicine

Metrics

Sustainability Highlights

News

» More